John Dobak, Chief Executive Officer at DermTech, Inc. (DMTK), sold 21,700 shares at $40.91 ($890K) on 2021-07-01, disclosed to the SEC on 2021-07-02.
Open-market sale of $890k DMTK by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.91 | 9,200 | $376K | 42.3% |
| 2 | $40.91 | 9,200 | $376K | 42.3% |
| 3 | $41.53 | 3,300 | $137K | 15.4% |
| Total | $41.00 avg | 21,700 | $890K | 100% |
| Filing → |
| DMTK | SELL | 2022-03-15 | $19K | — | Filing → |
| DMTK | SELL | 2022-03-09 | $43K | — | Filing → |
| DMTK | SELL | 2021-12-16 | $33K | — | Filing → |